FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2098132738> ?p ?o ?g. }

• W2098132738 endingPage "1589" @default.
• W2098132738 startingPage "1581" @default.
• W2098132738 abstract "The clearest advantage of new generation, atypical antipsychotics is a reduced risk of extrapyramidal side-effects (EPS), compared with conventional compounds. These findings might have been biased by the use of the high-potency antipsychotic haloperidol as a comparator in most of the trials. We aimed to establish whether the new drugs induce fewer EPS than low-potency conventional antipsychotics.We did a meta-analysis of all randomised controlled trials in which new generation antipsychotics had been compared with low-potency (equivalent or less potent than chlorpromazine) conventional drugs. We included studies that met quality criteria A or B in the Cochrane Collaboration Handbook, and assessed quality with the Jadad scale. The primary outcome of interest was the number of patients who had at least one EPS. We used risk differences and 95% CIs as measures of effect size.We identified 31 studies with a total of 2320 participants. Of the new generation drugs, only clozapine was associated with significantly fewer EPS (RD=-0.15, 95% CI -0.26 to -0.4, p=0.008) and higher efficacy than low-potency conventional drugs. Reduced frequency of EPS seen with olanzapine was of borderline significance (-0.15, -0.31 to -0.01, p=0.07). Only one inconclusive trial of amisulpride, quetiapine, and risperidone and no investigations of ziprasidone and sertindole were identified, but some evidence indicates that zotepine and remoxipride do not lead to fewer EPS than low-potency antipsychotics. Mean doses less than 600 mg/day of chlorpromazine or its equivalent had no higher risk of EPS than new generation drugs. As a group, new generation drugs were moderately more efficacious than low-potency antipsychotics, largely irrespective of the comparator doses used.Optimum doses of low-potency conventional antipsychotics might not induce more EPS than new generation drugs. Potential advantages in efficacy of the new generation drugs should be a factor in clinical treatment decisions to use these rather than conventional drugs." @default.
• W2098132738 created "2016-06-24" @default.
• W2098132738 creator A5002251483 @default.
• W2098132738 creator A5048912647 @default.
• W2098132738 creator A5061787713 @default.
• W2098132738 creator A5068206298 @default.
• W2098132738 date "2003-05-01" @default.
• W2098132738 modified "2023-10-11" @default.
• W2098132738 title "New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis" @default.
• W2098132738 cites W1965006338 @default.
• W2098132738 cites W1965860549 @default.
• W2098132738 cites W1967823517 @default.
• W2098132738 cites W1972545524 @default.
• W2098132738 cites W1977725618 @default.
• W2098132738 cites W1983547563 @default.
• W2098132738 cites W1986215651 @default.
• W2098132738 cites W1988897630 @default.
• W2098132738 cites W1990712459 @default.
• W2098132738 cites W1992083518 @default.
• W2098132738 cites W2006122360 @default.
• W2098132738 cites W2014118010 @default.
• W2098132738 cites W2016386797 @default.
• W2098132738 cites W2043101709 @default.
• W2098132738 cites W2062451323 @default.
• W2098132738 cites W2070640358 @default.
• W2098132738 cites W2078122061 @default.
• W2098132738 cites W2085360366 @default.
• W2098132738 cites W2096635847 @default.
• W2098132738 cites W2107328434 @default.
• W2098132738 cites W2110841701 @default.
• W2098132738 cites W2111665097 @default.
• W2098132738 cites W2113319228 @default.
• W2098132738 cites W2115125760 @default.
• W2098132738 cites W2119369900 @default.
• W2098132738 cites W2142411391 @default.
• W2098132738 cites W2157823046 @default.
• W2098132738 cites W2171179502 @default.
• W2098132738 cites W2410276058 @default.
• W2098132738 cites W4231480263 @default.
• W2098132738 doi "https://doi.org/10.1016/s0140-6736(03)13306-5" @default.
• W2098132738 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12747876" @default.
• W2098132738 hasPublicationYear "2003" @default.
• W2098132738 type Work @default.
• W2098132738 sameAs 2098132738 @default.
• W2098132738 citedByCount "655" @default.
• W2098132738 countsByYear W20981327382012 @default.
• W2098132738 countsByYear W20981327382013 @default.
• W2098132738 countsByYear W20981327382014 @default.
• W2098132738 countsByYear W20981327382015 @default.
• W2098132738 countsByYear W20981327382016 @default.
• W2098132738 countsByYear W20981327382017 @default.
• W2098132738 countsByYear W20981327382018 @default.
• W2098132738 countsByYear W20981327382019 @default.
• W2098132738 countsByYear W20981327382020 @default.
• W2098132738 countsByYear W20981327382021 @default.
• W2098132738 countsByYear W20981327382022 @default.
• W2098132738 countsByYear W20981327382023 @default.
• W2098132738 crossrefType "journal-article" @default.
• W2098132738 hasAuthorship W2098132738A5002251483 @default.
• W2098132738 hasAuthorship W2098132738A5048912647 @default.
• W2098132738 hasAuthorship W2098132738A5061787713 @default.
• W2098132738 hasAuthorship W2098132738A5068206298 @default.
• W2098132738 hasConcept C118552586 @default.
• W2098132738 hasConcept C126322002 @default.
• W2098132738 hasConcept C185592680 @default.
• W2098132738 hasConcept C202751555 @default.
• W2098132738 hasConcept C2776412080 @default.
• W2098132738 hasConcept C2776619155 @default.
• W2098132738 hasConcept C2777270317 @default.
• W2098132738 hasConcept C2778775820 @default.
• W2098132738 hasConcept C2778999636 @default.
• W2098132738 hasConcept C2780057945 @default.
• W2098132738 hasConcept C2780494398 @default.
• W2098132738 hasConcept C2780634440 @default.
• W2098132738 hasConcept C2780777758 @default.
• W2098132738 hasConcept C2780864610 @default.
• W2098132738 hasConcept C55493867 @default.
• W2098132738 hasConcept C57992300 @default.
• W2098132738 hasConcept C71924100 @default.
• W2098132738 hasConcept C98274493 @default.
• W2098132738 hasConceptScore W2098132738C118552586 @default.
• W2098132738 hasConceptScore W2098132738C126322002 @default.
• W2098132738 hasConceptScore W2098132738C185592680 @default.
• W2098132738 hasConceptScore W2098132738C202751555 @default.
• W2098132738 hasConceptScore W2098132738C2776412080 @default.
• W2098132738 hasConceptScore W2098132738C2776619155 @default.
• W2098132738 hasConceptScore W2098132738C2777270317 @default.
• W2098132738 hasConceptScore W2098132738C2778775820 @default.
• W2098132738 hasConceptScore W2098132738C2778999636 @default.
• W2098132738 hasConceptScore W2098132738C2780057945 @default.
• W2098132738 hasConceptScore W2098132738C2780494398 @default.
• W2098132738 hasConceptScore W2098132738C2780634440 @default.
• W2098132738 hasConceptScore W2098132738C2780777758 @default.
• W2098132738 hasConceptScore W2098132738C2780864610 @default.
• W2098132738 hasConceptScore W2098132738C55493867 @default.
• W2098132738 hasConceptScore W2098132738C57992300 @default.
• W2098132738 hasConceptScore W2098132738C71924100 @default.
• W2098132738 hasConceptScore W2098132738C98274493 @default.

• next